Last 12 months
Inside the activity.
6 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 21 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 3 |
| Apr 2026 | 2 | 5 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2019 Filed Jul 24, 2019 20:16 UTC |
Polaris Venture Partners V, L.P.10% owner
Flint Jonathan A10% owner
MCGUIRE TERRANCE10% owner
|
ConversionCommon Stock | 3,828,872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020231 · doc4.xml · nonDerivative · entry 1 Polaris Venture Management Co. V, L.L.C. · CIK 0001439589 · 10% owner Polaris Venture Partners Founders' Fund V, L.P. · CIK 0001439588 · 10% owner Polaris Venture Partners V, L.P. · CIK 0001439590 · 10% owner Polaris Venture Partners Entrepreneurs' Fund V, L.P. · CIK 0001439587 · 10% owner Polaris Venture Partners Special Founders' Fund V, L.P. · CIK 0001439586 · 10% owner Flint Jonathan A · CIK 0001295676 · 10% owner MCGUIRE TERRANCE · CIK 0001117003 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Venture Partners V, L.P. Disclosed balance after: 3,828,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date. F2 · ownership.nature: Jonathan A. Flint ("Flint") and Terrance G. McGuire ("McGuire") are the managing members of Polaris Venture Management Co. V, L.L.C. ("PVM"), which is the sole general partner for each of Polaris Venture Partners V, L.P. ("PVP V"), Polaris Venture Partners Entrepreneurs' Fund V, L.P. ("PVPEF V"), Polaris Venture Partners Founders' Fund V, L.P. ("PVPFF V"), and Polaris Venture Partners Special Founders' Fund V, L.P. ("PVPSF V", and together with PVP V, PVPEF V, and PVPFF V, the "Polaris Funds"). Each of Flint, McGuire, and PVM may be deemed to beneficially own the shares held by the Polaris Funds, but Flint, McGuire and PVM disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
CHV II, L.P.10% owner
Ascension Health Ventures II, LLC10% owner
|
ConversionSenior B Preferred Stock · Derivative | 1,139,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020229 · doc4.xml · derivative · entry 7 CHV II, L.P. · CIK 0001615761 · 10% owner Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By CHV II, L.P. Disclosed balance after: 0 Underlying: Common Stock · 492,424 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
CHV II, L.P.10% owner
Ascension Health Ventures II, LLC10% owner
|
ConversionSenior A Preferred Stock · Derivative | 1,082,016 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020229 · doc4.xml · derivative · entry 6 CHV II, L.P. · CIK 0001615761 · 10% owner Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By CHV II, L.P. Disclosed balance after: 0 Underlying: Common Stock · 518,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F3 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F3 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F3 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
CHV II, L.P.10% owner
Ascension Health Ventures II, LLC10% owner
|
ConversionJunior Convertible Preferred Stock · Derivative | 4,250,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020229 · doc4.xml · derivative · entry 5 CHV II, L.P. · CIK 0001615761 · 10% owner Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By CHV II, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,934,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
CHV II, L.P.10% owner
Ascension Health Ventures II, LLC10% owner
|
SaleCommon Stock | 335,767 | $18.00 | $6,043,806.00 |
DisclosureSEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 4 CHV II, L.P. · CIK 0001615761 · 10% owner Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By CHV II, L.P. Disclosed balance after: 2,609,482 F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
CHV II, L.P.10% owner
Ascension Health Ventures II, LLC10% owner
|
ConversionCommon Stock | 492,424 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 3 CHV II, L.P. · CIK 0001615761 · 10% owner Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By CHV II, L.P. Disclosed balance after: 2,945,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
CHV II, L.P.10% owner
Ascension Health Ventures II, LLC10% owner
|
ConversionCommon Stock | 518,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 2 CHV II, L.P. · CIK 0001615761 · 10% owner Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By CHV II, L.P. Disclosed balance after: 2,452,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
CHV II, L.P.10% owner
Ascension Health Ventures II, LLC10% owner
|
ConversionCommon Stock | 1,934,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020229 · doc4.xml · nonDerivative · entry 1 CHV II, L.P. · CIK 0001615761 · 10% owner Ascension Health Ventures II, LLC · CIK 0001615604 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By CHV II, L.P. Disclosed balance after: 1,934,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Junior Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Junior Convertible Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by CHV II, L.P. Ascension Health Ventures II, LLC dba Ascension Ventures II, LLC is the general partner of CHV II, L.P. Each of these entities expressly disclaims beneficial ownership of the shares listed above except to the extent of any pecuniary interest therein. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionSenior B Preferred Stock · Derivative | 113,980 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 10 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 51,872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionSenior B Preferred Stock · Derivative | 2,591,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 9 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 1,179,192 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F4 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionSenior A Preferred Stock · Derivative | 489,756 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 8 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 222,887 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionSenior A Preferred Stock · Derivative | 11,133,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · derivative · entry 7 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 5,066,835 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
SaleCommon Stock | 31,323 | $18.00 | $563,814.00 |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 6 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 243,436 F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
SaleCommon Stock | 712,065 | $18.00 | $12,817,170.00 |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 5 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,533,962 F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionCommon Stock | 51,872 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 4 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 274,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionCommon Stock | 1,179,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 3 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,246,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionCommon Stock | 222,887 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 2 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 222,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F3 · ownership.nature: Shares held directly by LLR Equity Partners Parallel IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners Parallel IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Perricelli ScottDirector
|
ConversionCommon Stock | 5,066,835 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020226 · doc4.xml · nonDerivative · entry 1 Perricelli Scott · CIK 0001776725 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,066,835 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior A Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior A Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by LLR Equity Partners IV, L.P. LLR Capital IV, L.P. is the general partner of LLR Equity Partners IV, L.P. LLR Capital IV, LLC is the general partner of LLR Capital IV, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his or its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Pegus CherylDirector
|
ConversionSenior B Preferred Stock · Derivative | 5,410,084 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020228 · doc4.xml · derivative · entry 3 Pegus Cheryl · CIK 0001572448 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Echo Health Ventures LLC Disclosed balance after: 0 Underlying: Common Stock · 2,462,128 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F1 · derivative.exercise_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F1 · derivative.expiration_date: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Pegus CherylDirector
|
SaleCommon Stock | 280,689 | $18.00 | $5,052,402.00 |
DisclosureSEC source: 0000899243-19-020228 · doc4.xml · nonDerivative · entry 2 Pegus Cheryl · CIK 0001572448 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Echo Health Ventures LLC Disclosed balance after: 2,181,439 F2 · ownership.nature: Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:15 UTC |
Pegus CherylDirector
|
ConversionCommon Stock | 2,462,128 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-020228 · doc4.xml · nonDerivative · entry 1 Pegus Cheryl · CIK 0001572448 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Echo Health Ventures LLC Disclosed balance after: 2,462,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon the closing of the Issuer's initial public offering, all shares of Senior B Preferred Stock automatically converted into shares of Common Stock of the Issuer on a one-for-2.1973 basis. The Senior B Preferred Stock had no expiration date. F2 · ownership.nature: Shares held directly by Echo Health Ventures LLC. Echo Health Ventures LLC is a joint venture between Cascadia Echo Holdings Company, LLC and Mosaic Health Solutions, LLC. Cascadia Echo Holdings LLC is a subsidiary of Cambia Health Solutions, LLC. The reporting person is the Chief Medical Officer and Senior Vice President of Cambia Health Solutions, LLC. The reporting person disclaims beneficial ownership over such shares, except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.